Baxter International Inc. Form 8-K Summary
Business Context and Reporting Period
This Current Report on Form 8-K was filed by Baxter International Inc. on February 13, 2006. The report discloses the entry into a material definitive agreement regarding the approval of compensatory arrangements for the Company's named executive officers by the Compensation Committee and independent directors.
Key Financial Metrics
The filing does not provide data on revenue, profit, cash flow, margins, debt, or liquidity. The financial figures disclosed are limited to executive compensation details:
- Robert L. Parkinson, Jr. (Chairman and CEO): 2005 Cash Bonus of $1,941,420; 2006 Salary of $1,200,000.
- Joy A. Amundson (President - BioScience): 2005 Cash Bonus of $770,280; 2006 Salary of $507,000.
- Peter J. Arduini (President - Medication Delivery): 2005 Cash Bonus of $364,540 (prorated); 2006 Salary of $482,000.
- John J. Greisch (CFO): 2005 Cash Bonus of $810,600; 2006 Salary of $572,000.
- James E. Utts (President - Europe): 2005 Cash Bonus of $462,120; 2006 Salary of $433,000.
Material Changes
The primary material change reported is the formal approval of 2006 salary structures and the finalization of 2005 cash bonuses for top executives. No material changes to the Company's financial position or operations are disclosed in this specific filing.
Guidance, Outlook, and Risks
The filing text does not provide guidance, outlook, management commentary on future performance, risks, contingencies, or unusual items. The document is strictly limited to the disclosure of executive compensation agreements.
Investor Verification Checklist
- Verify the total cash compensation payout for 2005 against the Company's annual proxy statement.
- Confirm the 2006 salary increases relative to prior years for each named executive officer.
- Note that Peter J. Arduini's 2005 bonus was prorated due to his employment duration during that year.
- Review the Company's most recent 10-K or 10-Q for comprehensive financial metrics not included in this 8-K.